Status:
COMPLETED
Comparing Acute Pain Management Protocols for Patients With Sickle Cell Disease
Lead Sponsor:
Duke University
Collaborating Sponsors:
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Sickle Cell Disease
Eligibility:
All Genders
21+ years
Phase:
PHASE4
Brief Summary
The goal of this pilot study is to improve emergency department (ED) pain management for adults with sickle cell disease. Sickle cell disease (SCD) is the most common genetic disorder in the United St...
Detailed Description
In August 2012 the National Heart, Lung, and Blood Institute (NHBLI) released for public comment their "Management of Sickle Cell Disease" evidence-based recommendations that were developed with conse...
Eligibility Criteria
Inclusion
- Adult SCD patients with genotypes SS, SC, SB+, or SB-
Exclusion
- Patients with sickle cell trait
- Allergic to both morphine sulfate and hydromorphone,
- Patients who have an explicit care plan that states they cannot be admitted to the hospital for pain control,
- Non-English speaking,
- Patients admitted for a medical complication,
- Record of \>24 ED visits in the prior 12 months,
- Children
Key Trial Info
Start Date :
March 15 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2016
Estimated Enrollment :
106 Patients enrolled
Trial Details
Trial ID
NCT02222246
Start Date
March 15 2015
End Date
June 30 2016
Last Update
August 4 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Mount Sinai Hospital
New York, New York, United States, 10029
2
University of Cincinnati Medical Center
Cincinnati, Ohio, United States, 45219